(Q54225770)

26 May 2018

http://europepmc.org/abstract/MED/24470379

title

Identification of RANBP2-ALK fusion in ALK positive diffuse large B-cell lymphoma. (English)

1 reference

26 May 2018

http://europepmc.org/abstract/MED/24470379

author

Kengo Takeuchi

3

1 reference

26 May 2018

http://europepmc.org/abstract/MED/24470379

author name string

Seung Eun Lee

1

1 reference

26 May 2018

http://europepmc.org/abstract/MED/24470379

So Young Kang

2

1 reference

26 May 2018

http://europepmc.org/abstract/MED/24470379

Young Hyeh Ko

4

1 reference

26 May 2018

http://europepmc.org/abstract/MED/24470379

publication date

27 January 2014

1 reference

26 May 2018

http://europepmc.org/abstract/MED/24470379

published in

Hematological Oncology

1 reference

26 May 2018

http://europepmc.org/abstract/MED/24470379

volume

32

1 reference

26 May 2018

http://europepmc.org/abstract/MED/24470379

issue

4

1 reference

26 May 2018

http://europepmc.org/abstract/MED/24470379

page(s)

221-224

1 reference

26 May 2018

http://europepmc.org/abstract/MED/24470379

cites work

Cytogenetically complex SEC31A-ALK fusions are recurrent in ALK-positive large B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FHON.2125

STAT3 pathway is activated in ALK-positive large B-cell lymphoma carrying SQSTM1-ALK rearrangement and provides a possible therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2125

Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2125

ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2125

Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2125

Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2125

Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2125

A Case of a Diffuse Large B-Cell Lymphoma of Plasmablastic Type Associated With the t(2;5)(p23;q35) Chromosome Translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2125

7 January 2021

ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases

1 reference

https://api.crossref.org/works/10.1002%2FHON.2125

7 January 2021

ALK-positive diffuse large B-cell lymphoma: report of three cases

1 reference

https://api.crossref.org/works/10.1002%2FHON.2125

7 January 2021

Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor

1 reference

https://api.crossref.org/works/10.1002%2FHON.2125

7 January 2021

Identifiers

DOI

10.1002/HON.2125

1 reference

26 May 2018

http://europepmc.org/abstract/MED/24470379

1 reference

26 May 2018